Lupin receives tentative USFDA approval for generic Sugammadex injection

Pharma major Lupin Ltd has received tentative approval from the USFDA for its generic Sugammadex injection, used to reverse muscle relaxants post-surgery. The approval is for specific strengths in single-dose vials and finds the generic bioequivalent to Merck's Bridion.